Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy

L.D. Locati; A. Piovesan; C. Durante; M. Bregni; M.G. Castagna; S. Zovato; M. Giusti; T. Ibrahim; E. Puxeddu; G. Fedele; G. Pellegriti; G. Rinaldi; D. Giuffrida; F. Verderame; F. Bertolini; C. Bergamini; A. Nervo; G. Grani; S. Rizzati; S. Morelli; I. Puliafito; R. Elisei

doi:10.1016/j.ejca.2019.05.031

Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy

L.D. Locati, A. Piovesan, C. Durante, M. Bregni, M.G. Castagna, S. Zovato, M. Giusti, T. Ibrahim, E. Puxeddu, G. Fedele, G. Pellegriti, G. Rinaldi, D. Giuffrida, F. Verderame, F. Bertolini, C. Bergamini, A. Nervo, G. Grani, S. Rizzati, S. MorelliI. Puliafito, R. Elisei

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	35-40
Number of pages	6
Journal	European Journal of Cancer
Volume	118
DOIs	https://doi.org/10.1016/j.ejca.2019.05.031
Publication status	Published - 2019

Access to Document

10.1016/j.ejca.2019.05.031

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068527088&doi=10.1016%2fj.ejca.2019.05.031&partnerID=40&md5=9f0b99192c77cd2a330cde9299b23cb6

Cite this

Locati, L. D., Piovesan, A., Durante, C., Bregni, M., Castagna, M. G., Zovato, S., Giusti, M., Ibrahim, T., Puxeddu, E., Fedele, G., Pellegriti, G., Rinaldi, G., Giuffrida, D., Verderame, F., Bertolini, F., Bergamini, C., Nervo, A., Grani, G., Rizzati, S., ... Elisei, R. (2019). Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy. European Journal of Cancer, 118, 35-40. https://doi.org/10.1016/j.ejca.2019.05.031

Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy. / Locati, L.D.; Piovesan, A.; Durante, C.; Bregni, M.; Castagna, M.G.; Zovato, S.; Giusti, M.; Ibrahim, T.; Puxeddu, E.; Fedele, G.; Pellegriti, G.; Rinaldi, G.; Giuffrida, D.; Verderame, F.; Bertolini, F.; Bergamini, C.; Nervo, A.; Grani, G.; Rizzati, S.; Morelli, S.; Puliafito, I.; Elisei, R.

In: European Journal of Cancer, Vol. 118, 2019, p. 35-40.

Research output: Contribution to journal › Article › peer-review

Locati, LD, Piovesan, A, Durante, C, Bregni, M, Castagna, MG, Zovato, S , Giusti, M , Ibrahim, T, Puxeddu, E, Fedele, G, Pellegriti, G, Rinaldi, G, Giuffrida, D, Verderame, F, Bertolini, F , Bergamini, C, Nervo, A, Grani, G, Rizzati, S, Morelli, S, Puliafito, I & Elisei, R 2019, 'Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy', European Journal of Cancer, vol. 118, pp. 35-40. https://doi.org/10.1016/j.ejca.2019.05.031

Locati, L.D. ; Piovesan, A. ; Durante, C. ; Bregni, M. ; Castagna, M.G. ; Zovato, S. ; Giusti, M. ; Ibrahim, T. ; Puxeddu, E. ; Fedele, G. ; Pellegriti, G. ; Rinaldi, G. ; Giuffrida, D. ; Verderame, F. ; Bertolini, F. ; Bergamini, C. ; Nervo, A. ; Grani, G. ; Rizzati, S. ; Morelli, S. ; Puliafito, I. ; Elisei, R. / Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy. In: European Journal of Cancer. 2019 ; Vol. 118. pp. 35-40.

@article{25aba07b5fb4476aa6020830bf55f7a6,

title = "Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy",

author = "L.D. Locati and A. Piovesan and C. Durante and M. Bregni and M.G. Castagna and S. Zovato and M. Giusti and T. Ibrahim and E. Puxeddu and G. Fedele and G. Pellegriti and G. Rinaldi and D. Giuffrida and F. Verderame and F. Bertolini and C. Bergamini and A. Nervo and G. Grani and S. Rizzati and S. Morelli and I. Puliafito and R. Elisei",

note = "Cited By :2 Export Date: 13 February 2020",

year = "2019",

doi = "10.1016/j.ejca.2019.05.031",

language = "English",

volume = "118",

pages = "35--40",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy

AU - Locati, L.D.

AU - Piovesan, A.

AU - Durante, C.

AU - Bregni, M.

AU - Castagna, M.G.

AU - Zovato, S.

AU - Giusti, M.

AU - Ibrahim, T.

AU - Puxeddu, E.

AU - Fedele, G.

AU - Pellegriti, G.

AU - Rinaldi, G.

AU - Giuffrida, D.

AU - Verderame, F.

AU - Bertolini, F.

AU - Bergamini, C.

AU - Nervo, A.

AU - Grani, G.

AU - Rizzati, S.

AU - Morelli, S.

AU - Puliafito, I.

AU - Elisei, R.

N1 - Cited By :2 Export Date: 13 February 2020

PY - 2019

Y1 - 2019

U2 - 10.1016/j.ejca.2019.05.031

DO - 10.1016/j.ejca.2019.05.031

M3 - Article

VL - 118

SP - 35

EP - 40

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -